[go: up one dir, main page]

AR050812A1 - Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos - Google Patents

Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos

Info

Publication number
AR050812A1
AR050812A1 ARP010102636A ARP010102636A AR050812A1 AR 050812 A1 AR050812 A1 AR 050812A1 AR P010102636 A ARP010102636 A AR P010102636A AR P010102636 A ARP010102636 A AR P010102636A AR 050812 A1 AR050812 A1 AR 050812A1
Authority
AR
Argentina
Prior art keywords
vegetable oils
oxygen
pharmacological solution
dimetilsulfoxide
medicines
Prior art date
Application number
ARP010102636A
Other languages
English (en)
Original Assignee
Stenti Haydee Alba
Pirillo Claudia Fernanda
Pastoriza Jose Maria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stenti Haydee Alba, Pirillo Claudia Fernanda, Pastoriza Jose Maria filed Critical Stenti Haydee Alba
Priority to ARP010102636A priority Critical patent/AR050812A1/es
Priority to US10/162,284 priority patent/US7270834B2/en
Publication of AR050812A1 publication Critical patent/AR050812A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Es una solucion farmacologica compuesta por dimetilsulfoxido, oxígeno ozonizado y aceites vegetales. La solucion farmacologica es para uso en medicina humana y veterinaria. Su aplicacion es externa, de forma topica. La composicion farmacéutica es util para tratar artritis, artrosis, dolores lumbares, dolores musculares, dolores dorsales, tendosinovitis, flebitis, bursitis, hematomas, edemas subcutáneas; afecciones de origen articular, sinovial, tendinoso y de la cápsula articular causados por entrenamiento deportivo en seres humanos y animales.
ARP010102636A 2001-06-01 2001-06-01 Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos AR050812A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ARP010102636A AR050812A1 (es) 2001-06-01 2001-06-01 Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos
US10/162,284 US7270834B2 (en) 2001-06-01 2002-06-03 Pharmaceutical composition comprising dimethylsulfoxide and ozone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP010102636A AR050812A1 (es) 2001-06-01 2001-06-01 Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos

Publications (1)

Publication Number Publication Date
AR050812A1 true AR050812A1 (es) 2006-11-29

Family

ID=37492497

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102636A AR050812A1 (es) 2001-06-01 2001-06-01 Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos

Country Status (2)

Country Link
US (1) US7270834B2 (es)
AR (1) AR050812A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615030B2 (en) * 2003-10-06 2009-11-10 Active O, Llc Apparatus and method for administering a therapeutic agent into tissue
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
WO2007033082A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
JP5399072B2 (ja) 2005-09-12 2014-01-29 アベラ ファーマスーティカルズ インコーポレイテッド ジメチルスルホキシド（ｄｍｓｏ）若しくは関連化合物、又はそれに関連する臭気を除去するシステム
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
CA2779111C (en) 2009-10-30 2019-08-13 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis
US20110319805A1 (en) * 2010-06-29 2011-12-29 Bryan Knicely Morris Topical composition for treating the skin
DE102012007239A1 (de) * 2012-04-10 2013-10-10 Wolfgang Winkelmann Pharmazeutische Zusammensetzung enthaltend eine mit Sauerstoff angereicherte ungesättigte Fettsäure und ein organisches Lösungsmittel
EP3305288B1 (en) 2016-10-10 2020-04-22 Dubaiomics FZ-LLC Cromoglycate for increasing hoof growth in ungulates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4932400A (en) * 1988-06-09 1990-06-12 James Persinger Method and apparatus for inhibiting shipping fever in livestock and improving digestibility of consumed feed
US6663874B2 (en) * 1998-11-02 2003-12-16 Victor Stevens Composition to alleviate pain and topical method of applying same

Also Published As

Publication number Publication date
US7270834B2 (en) 2007-09-18
US20020182263A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
AR050812A1 (es) Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos
CU22995A3 (es) Derivados de pirazolinas, su preparación y su aplicación como medicamentos
CL2003002621A1 (es) Composicion farmaceutica oral de liberacion controlada que comprende tramadol y topiramato, y su procedimiento de preparacion, util para tratar el dolor neuropatico.
CL2009000648A1 (es) Propeptido bmp-11 modificado en el residuo 98 de una secuencia bmp-11 humana; acido nucleico que lo codifica; composicion farmaceutica que lo comprende; metodo para preparar el propeptido, celula recombinante; uso del propeptido para tratar desordenes musculares, neuromusculares, metabolicos, y degenerativos de los huesos (divisional sol.224-02).
ES2159382T3 (es) Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones.
AR058679A1 (es) Preparacion farmaceutica que contiene meloxicam
GT200100134A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos
DK1032376T3 (da) Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse
CY1124710T1 (el) Κετυλιωμενα λιπαρα οξεα, συστημα για την παρασκευη αυτων και χρηση αυτων
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
PT1648484E (pt) Formulações para o tratamento de distúrbios artríticos
AR044350A1 (es) Manguito y parche analgesico microencapsulado de uso topico para el tratamiento del dolor
BRPI0517197A (pt) solução extrativa de resìduos de medicamentos veterinários em produtos de origem animal e frutos do mar
AR055107A1 (es) Furoato de n-{2-[((2s)-3-{[1-(4-clorobencil)piperidin-4-il]amino}-2-hidroxi-2-metilpropil)oxi]-4-hidroxifenil} acetamida,composiciones farmaceuticas que los contienen y usos para tratar afecciones o enfermedades donde actuan como moduladores del receptor de quimioquina 1(ccr1)
ES2281249B1 (es) Linimento analgesico antiinflamatorio.
CR6693A (es) Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productos medicinales y procesos para prepararlas
RU2012125066A (ru) Профилактическое средство и/или терапевтическое средство, и/или средство, подавляющее ухудшение при деформирующем артрите у человека
AR074521A1 (es) Asociacion de ingredientes activos que contienen un farmaco antiinflamatorio, no esteroideo y un derivado de colchicosido
Jawad et al. Cryotherapy treatment after arthroscopic knee debridement and ACL reconstruction: a review
AR029639A1 (es) Amidas sustituidas del acido fenilciclohexanocarboxilico, procedimiento para su preparacion, compuestos intermediarios, medicamentos, y el uso para la manufactura de un medicamento utiles como inhibidores de la incorporacion de adenosina
EA200401588A1 (ru) Средство для лечения болезней суставов
ES2387109A1 (es) Pulverización farmacéutica
AR030241A1 (es) Compuestos derivados de tienopirrolidinona, su uso, medicamentos que los contienen, un procedimiento para preparar dichos compuestos y compuestos intermediarios
TH134381A (th) สารรวมแบบใหม่ของส่วนผสมออกฤทธิ์ที่มียาต้านการอักเสบที่ไม่ใช่สเทอรอยด์ และ อนุพันธ์คอลคิโคไซด์
CA3026871A1 (en) A product comprising glucosamine for external application

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee